IsoRay (ISR) – Corporate News
-
IsoRay (ISR) Reports Study Showing Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray’s Cesium-131
-
IsoRay (ISR) Announces American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Cesium-131
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ISR Stock Lookup